Literature DB >> 6148297

Acute ulcerative colitis--a rare complication of sulfasalazine therapy.

H Ruppin, S Domschke.   

Abstract

A 43-year-old female suffering from ulcerative colitis did not improve under therapy with sulfasalazine. Following withdrawal of sulfasalazine and its replacement by systemic steroids and metronidazole++ she went into clinical and endoscopic remission. A second trial with sulfasalazine was, again, followed by a rapid and sever relapse of the colitis. On discontinuation of sulfasalazine therapy, gross inflammation resolved immediately. This adverse reaction to sulfasalazine has been reported previously in only four cases. The pathophysiology of this event is unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148297

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Colitis: problems in definition and diagnosis.

Authors:  R Whitehead
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  Comparative tolerability of therapies for ulcerative colitis.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Mesalazine induced exacerbation of ulcerative colitis.

Authors:  K C Kapur; G T Williams; M C Allison
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

4.  Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy.

Authors:  H Sandberg-Gertzén; G Järnerot; K Bukhave; K Lauritsen; J Rask-Madsen
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

Review 5.  Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease.

Authors:  G Järnerot
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.